Apple Watch Could Detect Hyperkalemia with AliveCor's KardiaBand, Study Finds
AliveCor announced on Monday that its FDA-approved KardiaBand Apple Watch band might be used to accurately detect hyperkalemia, besides its already confirmed EKG (electrocardiography) capabilities.
Two new studies conducted by a Cleveland Clinic in Ohio, U.S. confirm that AliveCor’s portable electrocardiogram (ECG) KardiaBand for Apple’s Apple Watch smartwatch offers groundbreaking health monitoring capabilities, including the detection of atrial fibrillation (AFib) and hyperkalemia, a.k.a. high potassium levels in the blood.
“As our team continues to push the bounds on innovation in digital health, we are on a path to changing the way AFib and hyperkalemia can be detected, and to defining the ways in which products like Apple Watch can play a role in the future of health care,” said Vic Gundotra, CEO of AliveCor in the press release.